DOI QR코드

DOI QR Code

3D-QSAR Study of Melanin Inhibiting (S)-(+)-Decursin and its Analogues by Pharmacophore Mapping

  • Lee, Kyeong (College of pharmacy, Dongguk University) ;
  • Jung, Sang-Won (Department of Bioinformatics, Korea University) ;
  • Naik, Ravi (College of pharmacy, Dongguk University) ;
  • Cho, Art E. (Department of Bioinformatics, Korea University)
  • Received : 2011.09.30
  • Accepted : 2011.11.15
  • Published : 2012.01.20

Abstract

The (S)-(+)-decursin and its analogues are reported as potent inhibitors of melanin production in B16 murine melanoma cells. In order to understand the factors responsible for potency as well as inhibition of potency of (S)-(+)-decursin and its analogues, three-dimensional quantitative structure-activity relationship (3D-QSAR) studies were performed. Since receptor structures are not available, a pharmacophore model was constructed. Using PHASE, we generated 3 different models and selected the seven-site model, which returned excellent statistical values ($r^2$ = 0.9127, $Q^2$ = 0.6878, Pearson-R = 0.9014). Using the generated pharmacophore model, we screened a natural products library and obtained 4'-epi-decursin as the most related compound. 4'-epidecursin is similar to (S)-(+)-decursin, but shows additional interaction possibilities with tyrosinase. The study thus sheds some light on possibility of developing more potent tyrosinase inhibitors.

Keywords

References

  1. Watt, B.; Rapaso, G.; Mark, M. S. Func. Amyloid Aggregation 2010, 89-113.
  2. Lee, K.; Lee, J. H.; Boovanahalli, S. K.; Choi, Y.; Choo, S.-J.; Yoo, I.-D.; Kim, D. H.; Yun, M. Y.; Lee, G. W.; Song, G. Y. Eur. J. Med. Chem. 2010, 45, 5567-5575. https://doi.org/10.1016/j.ejmech.2010.09.006
  3. Mapunya, M. B.; Hussein, A. A.; Rodriguez, B.; Lall, N. Phytomedicine 2011, 18(11), 1006-1012.
  4. Lee, N. K.; Son, K. H.; Chang, H. W.; Kang, S. S.; Park, H.; Heo, M. Y.; Kim, H. P. Arch. Pharm. Res. 2004, 27, 1132-1135. https://doi.org/10.1007/BF02975118
  5. Solano, F.; Briganti, S.; Picardo, M.; Ghanem, G. Pigment Cell. Res. 2006, 550-571.
  6. Curto, E. V.; Kwong, C.; Hermersdorfer, H.; Glatt, H.; Santis, C.; Virador, V.; Hearing, V. J.; Dooley, T. P. Biochem. Pharmacol. 1999, 57, 663-672. https://doi.org/10.1016/S0006-2952(98)00340-2
  7. Chung, J. Y.; Pasha, F. A.; Cho, S. J.; Won, M.; Lee, J. J.; Lee, K. Arch. Pharm. Res. 2009, 32(3), 317-323. https://doi.org/10.1007/s12272-009-1301-3
  8. Gadhe, C. G.; Madhavan, G.; Kothandan, G.; Lee, T. B.; Lee, K.; Cho, S. J. Bull. Korean Chem. Soc. 2011, 32(5), 1-7.
  9. Kubo, I.; Nihei, K.; Tsujimoto, K. Bioorg. Med. Chem. 2004, 12, 5349-5354. https://doi.org/10.1016/j.bmc.2004.07.052
  10. Wei, Y.; Carole, D.; Samir, Y.; Ramain, H.; Catherine, B.; Huacan, S.; Renaud, H.; Marius, R.; Ahcène, B. Eur. J. Med. Chem. 2011, 46, 4330-4335. https://doi.org/10.1016/j.ejmech.2011.07.003
  11. Okombi, S.; Rival, D.; Bonnet, S.; Mariotte, A. M.; Perrier, E.; Boumendjel, A. Bioorg. Med. Chem. Lett. 2006, 16, 2252-2255. https://doi.org/10.1016/j.bmcl.2006.01.022
  12. Kummala, T.; Vuorela, P.; Johansson, S.; Bohlin, L.; Vuorela, H.; Vasange, M. Pharmaceut. Pharmacol. Lett. 1998, 8, 144-147.
  13. Sano, K.; Yosioka, I.; Kitawa, I. Chem. Pharm. Bull. 1975, 23, 20- 28. https://doi.org/10.1248/cpb.23.20
  14. LigPrep, version 2.5, Schrodinger, LLC, New York, NY, 2011.
  15. Watts, K. S.; Dalai, P.; Murphy, R. B.; Sherman, W.; Friesner, R. A.; Shelley, J. C. J. Chem. Inf. Model. 2010, 50, 534-546. https://doi.org/10.1021/ci100015j
  16. Dixon, S. L.; Smondyrev, A. M.; Knoll, E. H.; Shaw, D. E.; Friesner, R. A. J. Comput. Aided Mol. Des. 2006, 20, 647-671. https://doi.org/10.1007/s10822-006-9087-6
  17. Dixon, S. L.; Smondyrev, A. M.; Rao, S. N. Chem. Biol. Drug. Des. 2006, 67, 370-372.
  18. Irwin, J. J.; Schoichet, B. K. J. Chem. Inf. Model. 2005, 45, 177-182. https://doi.org/10.1021/ci049714+
  19. Matoba, M.; Kumagi, T.; Yamamoto, A.; Yoshitsu, H.; Sugiyama, M. J. Biol. Chem. 2006, 281, 8981-8990. https://doi.org/10.1074/jbc.M509785200

Cited by

  1. QSAR of phytochemicals for the design of better drugs vol.7, pp.10, 2012, https://doi.org/10.1517/17460441.2012.716420